Poloppin is a potent, cell penetrant inhibitor of the mitotic Polo-like kinase (PLK) (IC50=26.9 µM) and prevents the protein-protein interaction via the Polo-box domain (PBD) (Kd= 29.5 µM). Poloppin selectively kills cells expressing mutant KRAS, enhancing death in mitosis. Poloppin is used for the study of KRAS-mutant cancers as single agents, or in combination with c-MET inhibitors[1].
Molekulargewicht:
438.24
CAS Nummer:
[683808-78-8]
Formel:
C20H15BrF3NO2
Target-Kategorie:
Autophagy,Mitosis,Polo-like Kinase (PLK)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten